The shingles vaccine could do double duty as a protector against both infections and dementia, according to a new study.

GSK plc (LSE/NYSE: GSK) has today released global survey data showing that over half (52%) of people aged 50-60 feel younger than their age—and nearly a fifth (19%) feel as much as a decade younger.

But new research into a common vaccine could offer some hope. According to a new study in Nature, the vaccine for shingles could significantly reduce the risk of dementia. These findings, the ...